Statistical methodology of phase III cancer clinical trials: advances and future perspectives. ανά Sylvester, R, Van Glabbeke, M, Collette, L, Suciu, S, Baron, B, Legrand, C, Gorlia, T, Collins, G, Coens, C, Declerck, L, Therasse, P

Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). ανά Popov, I, Carrato, A, Sobrero, A, Vincent, M, Kerr, D, Labianca, R, Raffaele Bianco, A, El-Serafi, M, Bedenne, L, Paillot, B, Mini, E, Sanches, E, Welch, J, Collette, L, Praet, M, Wils, J